GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Welcia Holdings Co Ltd (TSE:3141) » Definitions » Sloan Ratio %

Welcia Holdings Co (TSE:3141) Sloan Ratio % : 0.00% (As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Welcia Holdings Co Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Welcia Holdings Co's Sloan Ratio for the quarter that ended in Nov. 2023 was 0.00%.

As of Nov. 2023, Welcia Holdings Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Welcia Holdings Co Sloan Ratio % Historical Data

The historical data trend for Welcia Holdings Co's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welcia Holdings Co Sloan Ratio % Chart

Welcia Holdings Co Annual Data
Trend Aug14 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.10 -0.52 10.22 0.52 0.35

Welcia Holdings Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Welcia Holdings Co's Sloan Ratio %

For the Pharmaceutical Retailers subindustry, Welcia Holdings Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Welcia Holdings Co's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Welcia Holdings Co's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Welcia Holdings Co's Sloan Ratio % falls into.



Welcia Holdings Co Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Welcia Holdings Co's Sloan Ratio for the fiscal year that ended in Feb. 2024 is calculated as

Sloan Ratio=(Net Income (A: Feb. 2024 )-Cash Flow from Operations (A: Feb. 2024 )
-Cash Flow from Investing (A: Feb. 2024 ))/Total Assets (A: Feb. 2024 )
=(26451-46529
--22028)/551860
=0.35%

Welcia Holdings Co's Sloan Ratio for the quarter that ended in Nov. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Nov. 2023 )
=(26276-0
-0)/550673
=4.77%

Welcia Holdings Co's Net Income for the trailing twelve months (TTM) ended in Nov. 2023 was 5894 (Feb. 2023 ) + 5126 (May. 2023 ) + 11107 (Aug. 2023 ) + 4149 (Nov. 2023 ) = 円26,276 Mil.
Welcia Holdings Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Nov. 2023 was 0 (Feb. 2023 ) + 0 (May. 2023 ) + 0 (Aug. 2023 ) + 0 (Nov. 2023 ) = 円0 Mil.
Welcia Holdings Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Nov. 2023 was 0 (Feb. 2023 ) + 0 (May. 2023 ) + 0 (Aug. 2023 ) + 0 (Nov. 2023 ) = 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Welcia Holdings Co  (TSE:3141) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Nov. 2023, Welcia Holdings Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Welcia Holdings Co Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Welcia Holdings Co's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Welcia Holdings Co (TSE:3141) Business Description

Traded in Other Exchanges
Address
2-2-15 Outside Kanda, Chiyoda-ku, Tokyo, JPN, 101-0021
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.

Welcia Holdings Co (TSE:3141) Headlines

No Headlines